• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA warns about counterfeit versions of Novo's diabetes drug Ozempic

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 22, 2023 at 09:52: AM
via The U.S. Food and Drug Administration on Thursday warned consumers not to use counterfeit versions of Novo Nordisk's (NOVOb.CO) diabetes drug Ozempic that have been found in the country's drug supply chain.

article source
 




Top Bottom
Back
Quote